Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Peter Schiff Enterprises is a private U.S. medical device company focused on cardiovascular surgical equipment used in open-heart procedures. The company describes itself as the original manufacturer of battery-operated AC cardiac fibrillators and also supplies electrode pads, cables, connectors, and adapter cables for implantable cardioverter-defibrillator implantation. Its core marketed product appears to be the Model 310C cardiac fibrillator, a battery-operated device used intraoperatively. The business is commercial-stage rather than drug-development oriented, with activity centered on manufacturing and supplying specialized cardiac surgery devices and accessories.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Peter Schiff Enterprises.